BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15140410)

  • 1. Purinergic signalling in the lung: important in asthma and COPD?
    Adriaensen D; Timmermans JP
    Curr Opin Pharmacol; 2004 Jun; 4(3):207-14. PubMed ID: 15140410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway nitrergic pathways: is there therapeutic potential in asthma and COPD?
    Folkerts G; Nijkamp FP
    Curr Opin Pharmacol; 2004 Jun; 4(3):202-6. PubMed ID: 15140409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-9 as a possible therapeutic target in both asthma and chronic obstructive airways disease.
    McNamara PS; Smyth RL
    Drug News Perspect; 2005 Dec; 18(10):615-21. PubMed ID: 16491163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy.
    Kirkham P; Rahman I
    Pharmacol Ther; 2006 Aug; 111(2):476-94. PubMed ID: 16458359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purinergic signaling in the airways.
    Burnstock G; Brouns I; Adriaensen D; Timmermans JP
    Pharmacol Rev; 2012 Oct; 64(4):834-68. PubMed ID: 22885703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATP and the pathogenesis of COPD.
    Mortaz E; Folkerts G; Nijkamp FP; Henricks PA
    Eur J Pharmacol; 2010 Jul; 638(1-3):1-4. PubMed ID: 20423711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis: a potentially critical part of remodelling in chronic airway diseases?
    Walters EH; Reid D; Soltani A; Ward C
    Pharmacol Ther; 2008 Apr; 118(1):128-37. PubMed ID: 18358536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The overlap syndrome of asthma and COPD: what are its features and how important is it?
    Gibson PG; Simpson JL
    Thorax; 2009 Aug; 64(8):728-35. PubMed ID: 19638566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation?
    Gwilt CR; Donnelly LE; Rogers DF
    Pharmacol Ther; 2007 Aug; 115(2):208-22. PubMed ID: 17597218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediators of chronic obstructive pulmonary disease.
    Barnes PJ
    Pharmacol Rev; 2004 Dec; 56(4):515-48. PubMed ID: 15602009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoventilation in asthma and chronic obstructive pulmonary disease.
    Beuther DA
    Semin Respir Crit Care Med; 2009 Jun; 30(3):321-9. PubMed ID: 19452392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endogenous nitric oxide in obstructive pulmonary diseases].
    Toczyska I; Chciałowski A; Lubiński W
    Wiad Lek; 2005; 58(3-4):238-42. PubMed ID: 16119172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factors in asthma and COPD.
    Caramori G; Ito K; Adcock IM
    IDrugs; 2004 Aug; 7(8):764-70. PubMed ID: 15334310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases in asthma and COPD.
    Demedts IK; Brusselle GG; Bracke KR; Vermaelen KY; Pauwels RA
    Curr Opin Pharmacol; 2005 Jun; 5(3):257-63. PubMed ID: 15907912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Similarities and differences between asthma and copd: pathophysiological and therapeu tic aspects].
    Ichinose M
    Arerugi; 2008 Nov; 57(11):1124-33. PubMed ID: 19052507
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of different therapeutic strategies on exhaled NO and lung inflammation in asthma and COPD.
    Kharitonov SA
    Vascul Pharmacol; 2005 Dec; 43(6):371-8. PubMed ID: 16198155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Airway sensory nerve and tachykinins in asthma and COPD].
    Dinh QT; Klapp BF; Fischer A
    Pneumologie; 2006 Feb; 60(2):80-5. PubMed ID: 16463247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rho kinase as a therapeutic target in the treatment of asthma and chronic obstructive pulmonary disease.
    Fernandes LB; Henry PJ; Goldie RG
    Ther Adv Respir Dis; 2007 Oct; 1(1):25-33. PubMed ID: 19124345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine-receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease.
    Polosa R
    Eur Respir J; 2002 Aug; 20(2):488-96. PubMed ID: 12212985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma.
    Hollander C; Sitkauskiene B; Sakalauskas R; Westin U; Janciauskiene SM
    Respir Med; 2007 Sep; 101(9):1947-53. PubMed ID: 17574828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.